Unitaid is investing US$28.6 million to expand access to testing for multiple diseases. Through two complementary projects led by the Aurum Institute and Benin’s National Tuberculosis Program, the investment will explore how countries can better connect diagnostic services, identify conditions that might otherwise go undetected and help more people get the tests and care they need.
The work will span countries across Africa and Asia and focus on diseases including tuberculosis (TB), HIV, the human papillomavirus (HPV) and other sexually transmitted infections (STIs). It will also explore how diagnostic platforms and services for these diseases can be used to expand access to testing for other conditions.
Today, health services, including testing, are often organized around single diseases. As a result, people may need to make repeated visits to health facilities, wait longer for a diagnosis or miss out on tests they need. The Lancet Commission on Diagnostics estimates that nearly half of the world’s population has little or no access to essential diagnostic services. This can delay treatment and contribute to the spread of disease.
Follow us on WhatsApp | LinkedIn for the latest headlines
The projects will explore how countries can connect services across diseases; for example, by offering additional relevant tests during a single health visit or sharing diagnostics platforms and sample referral networks. It will examine the full pathway from testing and diagnosis to referral and treatment, and generate evidence on when and where integrated approaches can benefit patients and health systems, what they cost and how countries can sustain them.
